Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
|Slideshows|October 3, 2019
Fysh debuts fall collection of linear and lightweight designs
Author(s)Alex Delaney-Gesing, Senior Editor
Advertisement
Thin, linear designs and lightweight constructions define the Fysh collection for Fall 2019. With patterns and contemporary color combinations, these new styles feature an unconventional play with shapes.
Advertisement
Related to this article
FDA advisers review SYD-101, low-dose atropine 0.01% for pediatric myopia, on Oct 30 after a 2025 complete response letter.
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
The screen time question: What to ask and when to look deeper
2
FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee
3
The Independent Advantage S02 E06: Taking the strain of undesirable tasks off staff with AI
4
AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa
5